Progression from prediabetes to type 2 diabetes mellitus in adolescents: a real world experience

被引:6
作者
Weiner, Alyson [1 ]
Zhang, Meng [2 ]
Ren, Sheng [2 ]
Tchang, Beverly [1 ]
Gandica, Rachelle [3 ]
Murillo, Jaime [2 ]
机构
[1] Comprehens Weight Control Ctr, Div Endocrinol Diabet & Metab, Weill Cornell Med, New York, NY 10065 USA
[2] Optum Labs, Eden Prairie, MN USA
[3] Columbia Univ, Irving Med Ctr, Div Pediat Endocrinol Diabet & Metab, New York, NY USA
来源
FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE | 2023年 / 4卷
关键词
prediabetes; adolescents; metformin; type; 2; diabetes; pediatric diabetes care; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; FOLLOW-UP; METFORMIN; YOUTH; CHILDREN; OBESITY; COHORT;
D O I
10.3389/fcdhc.2023.1181729
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Obesity in pediatric patients is strongly associated with increased vascular and metabolic risk. Prediabetes is present in up to 1 in 5 adolescents, aged 12-18 years-old, though is thought to remit spontaneously in a significant portion. Pediatric patients with type 2 diabetes mellitus (T2D) have a more rapid decline of beta-cell function and progression to treatment failure than adult T2D patients. Thus, there is a strong interest in better understanding the natural history of prediabetes in these youth. We aimed to evaluate the real-world rate of progression of prediabetes to T2D in adolescent patients.Methods This is a retrospective study of 9,275 adolescent subjects aged 12-21 years-old with at least 3 years of de-identified commercial claims data and a new diagnosis of prediabetes during the observation period. Enrollees with a T2D diagnosis and/or diabetes medication use in the 1 year prior to prediabetes diagnosis or a T2D diagnosis in the 1 month following prediabetes diagnosis were excluded. Enrollees with diagnoses of type 1 diabetes (T1D) or polycystic ovarian syndrome over the 3 years were also excluded. Progression to T2D was defined by claims data of two T2D diagnoses at least 7 days apart, HbA1c >= 6.5%, and/or prescription of insulin without known T1D. Enrollees were followed for 2 years after prediabetes diagnosis.Results Overall, 232 subjects (2.5%) progressed from prediabetes to T2D. There were no differences found in T2D progression based on sex or age. Progression to T2D occurred at a median of 302 days after prediabetes diagnosis (IQR 123 to 518 days). This study was limited by the lack of laboratory/anthropometric data in administrative claims, as well as the exclusion of 23,825 enrollees for lack of continuous commercial claims data over 3 years.Conclusion In the largest sample to date on adolescent prediabetes, we found a 2.5% progression of prediabetes to T2D over a median duration of about one year.
引用
收藏
页数:6
相关论文
共 30 条
  • [2] Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016
    Andes, Linda J.
    Cheng, Yiling
    Rolka, Deborah B.
    Gregg, Edward W.
    Imperatore, Giuseppina
    [J]. JAMA PEDIATRICS, 2020, 174 (02)
  • [3] Progressive deterioration of β-cell function inobese youth with type 2 diabetes
    Bacha, Fida
    Gungor, Neslihan
    Lee, SoJung
    Arslanian, Silva A.
    [J]. PEDIATRIC DIABETES, 2013, 14 (02) : 106 - 111
  • [4] Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study
    Bacha, Fida
    Pyle, Laura
    Nadeau, Kristen
    Cuttler, Leona
    Goland, Robin
    Haymond, Morey
    Levitsky, Lynne
    Lynch, Jane
    Weinstock, Ruth S.
    White, Neil H.
    Caprio, Sonia
    Arslanian, Silva
    [J]. PEDIATRIC DIABETES, 2012, 13 (05) : 377 - 384
  • [5] Characteristics of Adolescents and Youth with Recent-Onset Type 2 Diabetes: The TODAY Cohort at Baseline
    Copeland, Kenneth C.
    Zeitler, Philip
    Geffner, Mitchell
    Guandalini, Cindy
    Higgins, Janine
    Hirst, Kathryn
    Kaufman, Francine R.
    Linder, Barbara
    Marcovina, Santica
    McGuigan, Paul
    Pyle, Laura
    Tamborlane, William
    Willi, Steven
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (01) : 159 - 167
  • [6] ElSayed NA, 2023, DIABETES CARE, V46, pS41, DOI [10.2337/dc23-ad08a, 10.2337/dc23-S003]
  • [7] Treatment of Type 2 Diabetes in Youth
    Flint, Amanda
    Arslanian, Silva
    [J]. DIABETES CARE, 2011, 34 : S177 - S183
  • [8] Trajectories of changes in glucose tolerance in a multiethnic cohort of obese youths: an observational prospective analysis
    Galderisi, Alfonso
    Giannini, Cosimo
    Weiss, Ram
    Kim, Grace
    Shabanova, Veronika
    Santoro, Nicola
    Pierpont, Bridget
    Savoye, Mary
    Caprio, Sonia
    [J]. LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (10) : 726 - 735
  • [9] Optimal Macronutrient Content of the Diet for Adolescents With Prediabetes; RESIST a Randomised Control Trial
    Garnett, Sarah P.
    Gow, Megan
    Ho, Mandy
    Baur, Louise A.
    Noakes, Manny
    Woodhead, Helen J.
    Broderick, Carolyn R.
    Burrell, Susie
    Chisholm, Kerryn
    Halim, Jocelyn
    De, Sukanya
    Steinbeck, Katherine
    Srinivasan, Shubha
    Ambler, Geoffrey R.
    Kohn, Michael R.
    Cowell, Chris T.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (05) : 2116 - 2125
  • [10] Youth type 2 diabetes -: Insulin resistance, β-cell failure, or both?
    Gungor, N
    Bacha, F
    Saad, R
    Janosky, J
    Arslanian, S
    [J]. DIABETES CARE, 2005, 28 (03) : 638 - 644